Applying therapist-guided digital cognitive behavioral therapy for insomnia in psychiatry: a mixed-methods process evaluation

被引：0
作者：
J. E. Reesen [1 ]
F. M. van de Kamer [2 ]
A. E. van Keeken [1 ]
S. L.C. Ikelaar [1 ]
P. van Oppen [1 ]
N. Batelaan [3 ]
J. Lancee [4 ]
E. J.W. van Someren [3 ]
F. van Nassau [4 ]
机构：
[1] Department of Sleep and Cognition, Netherlands Institute for Neuroscience, Royal Netherlands, Academy of Arts and Sciences, Amsterdam
[2] Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit University Amsterdam, Amsterdam
[3] Department of Psychiatry, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam
[4] GGZ inGeest Mental Health Care, Amsterdam
[5] Department of Psychiatry, Amsterdam Public Health research institute, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam
[6] Department of Clinical Psychology, University of Amsterdam, Amsterdam
[7] Amsterdam Neuroscience, Mood Anxiety Psychosis Stress Sleep, Amsterdam
[8] Department of Public and Occupational Health, Amsterdam Public Health research institute, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam
来源：
BMC Psychiatry | / 25卷 / 1期
基金：
英国惠康基金;
关键词：
CBT-I; Hybrid type 2; Insomnia; Process evaluation;
D O I：
10.1186/s12888-025-06824-1
中图分类号：
学科分类号：
摘要：
Introduction: Insomnia is prevalent, particularly among individuals with mental health complaints. However, Cognitive Behavioral Therapy for Insomnia (CBT-I), the first-line treatment, is underutilized in care settings. This study evaluated a therapist-guided digital CBT-I (i-Sleep), gathering insights from participants and therapists to optimize the intervention and inform implementation strategies. Methods: A mixed-methods process evaluation, guided by the RE-AIM framework, was conducted alongside an effectiveness trial. Data were collected from i-Sleep participants with clinically relevant insomnia and various mental health complaints across all care levels, ranging from pre-clinical (unattended), to those referred to general or specialized care. Additionally, data were collected from i-Sleep therapists. Results: A total of 181 i-Sleep participants (mean age = 46.7 years, SD = 13.2) enrolled, with an attrition rate of 21.6%. Participants reported benefits including faster sleep onset, fewer nighttime awakenings, increased daytime energy, and positive lifestyle changes, though some experienced minimal gains or adverse effects. Satisfaction with the intervention ranged from 7.1 to 7.3 across care levels. Post-intervention, 89.4% of all participants indicated they would recommend iCBT-I. Satisfaction with therapist guidance was high (M = 7.7–8.3), though preferences for format and frequency varied. Therapists (n = 15, mean experience = 0.8 years, SD = 1.1) suggested addressing practical constraints and enhancing training for better integration into routine care. Conclusion: Our findings highlight the feasibility and potential of therapist-guided iCBT-I to improve sleep in individuals with mental health complaints across all care settings. Universal implementation could offer significant benefits, while adaptable content and flexible guidance may better meet individual needs. Trial registration: Netherlands Trial Register (NL9776) registered on 07/10/2021. © The Author(s) 2025.
引用
收藏
相关论文
共 62 条
  • [1] Riemann D., Et al., The European insomnia guideline: an update on the diagnosis and treatment of insomnia 2023, J Sleep Res, 32, 6, (2023)
  • [2] Morin C.M., Jarrin D.C., Epidemiology of insomnia: prevalence, course, risk factors, and public health burden, Sleep Med Clin, 17, 2, pp. 173-191, (2022)
  • [3] Hertenstein E., Et al., Insomnia as a predictor of mental disorders: A systematic review and meta-analysis, Sleep Med Rev, 43, pp. 96-105, (2019)
  • [4] Sofi F., Et al., Insomnia and risk of cardiovascular disease: a meta-analysis, Eur J Prev Cardiol, 21, 1, pp. 57-64, (2014)
  • [5] Anothaisintawee T., Et al., Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis, Sleep Med Rev, 30, pp. 11-24, (2016)
  • [6] Seow L.S.E., Et al., Evaluating DSM-5 insomnia disorder and the treatment of sleep problems in a psychiatric population, J Clin Sleep Med, 14, 2, pp. 237-244, (2018)
  • [7] Chan J.W., Et al., Eveningness and insomnia: independent risk factors of nonremission in major depressive disorder, Sleep, 37, 5, pp. 911-917, (2014)
  • [8] Ng C.-L., The relationships between insomnia & depression, J Family Med Community Health, 2, 1, (2015)
  • [9] Ree M., Junge M., Cunnington D., Australasian sleep association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adults, Sleep Med, 36, pp. S43-S47, (2017)
  • [10] van Straten A., Et al., Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis, Sleep Med Rev, 38, pp. 3-16, (2018)
1234567